Belinda Ha

1.8k total citations · 1 hit paper
35 papers, 1.3k citations indexed

About

Belinda Ha is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Belinda Ha has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 19 papers in Emergency Medicine and 17 papers in Virology. Recurrent topics in Belinda Ha's work include HIV/AIDS drug development and treatment (20 papers), HIV-related health complications and treatments (19 papers) and HIV Research and Treatment (17 papers). Belinda Ha is often cited by papers focused on HIV/AIDS drug development and treatment (20 papers), HIV-related health complications and treatments (19 papers) and HIV Research and Treatment (17 papers). Belinda Ha collaborates with scholars based in United States, Netherlands and Japan. Belinda Ha's co-authors include Paul E. Sax, Camlin Tierney, Eric S. Daar, Grace A. McComsey, Nasreen C. Jahed, Douglas Kitch, Kathleen Melbourne, Laurie Myers, Pablo Tebas and Ann C. Collier and has published in prestigious journals such as New England Journal of Medicine, The Journal of Infectious Diseases and AIDS.

In The Last Decade

Belinda Ha

34 papers receiving 1.3k citations

Hit Papers

Bone Mineral Density and Fractures in Antiretroviral-Naiv... 2011 2026 2016 2021 2011 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
    2011 381 citations Grace A. McComsey, Douglas Kitch et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Belinda Ha United States 15 901 801 637 209 172 35 1.3k
Henning Drechsler United States 14 614 0.7× 532 0.7× 382 0.6× 137 0.7× 267 1.6× 25 1.0k
S. Lawson‐Ayayi France 16 526 0.6× 585 0.7× 279 0.4× 143 0.7× 191 1.1× 30 1000
Allison Ross Eckard United States 18 401 0.4× 618 0.8× 256 0.4× 55 0.3× 150 0.9× 47 956
Aoife G. Cotter Ireland 14 448 0.5× 412 0.5× 206 0.3× 140 0.7× 149 0.9× 43 825
Beverly Alston‐Smith United States 13 421 0.5× 610 0.8× 281 0.4× 73 0.3× 329 1.9× 23 1.0k
Roula Qaqish United States 10 649 0.7× 961 1.2× 416 0.7× 492 2.4× 231 1.3× 17 1.4k
Allison C. Ross United States 11 209 0.2× 512 0.6× 199 0.3× 68 0.3× 100 0.6× 18 678
Paola Cicconi Italy 17 489 0.5× 301 0.4× 369 0.6× 44 0.2× 351 2.0× 45 881
Jean‐Philippe Chave Switzerland 16 864 1.0× 474 0.6× 493 0.8× 21 0.1× 499 2.9× 21 1.3k
Valerianna Amorosa United States 18 375 0.4× 286 0.4× 143 0.2× 67 0.3× 346 2.0× 36 888

Countries citing papers authored by Belinda Ha

Since Specialization
Citations

This map shows the geographic impact of Belinda Ha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belinda Ha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belinda Ha more than expected).

Fields of papers citing papers by Belinda Ha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belinda Ha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belinda Ha. The network helps show where Belinda Ha may publish in the future.

Co-authorship network of co-authors of Belinda Ha

This figure shows the co-authorship network connecting the top 25 collaborators of Belinda Ha. A scholar is included among the top collaborators of Belinda Ha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belinda Ha. Belinda Ha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Samir K., Douglas Kitch, Todd T. Brown, et al.. (2017). Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s. PMC. 1 indexed citations
2.
Grant, Philip, Douglas Kitch, Grace A. McComsey, et al.. (2016). Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals. The Journal of Infectious Diseases. 214(4). 607–611. 37 indexed citations
3.
Wyatt, Christina, Douglas Kitch, Samir K. Gupta, et al.. (2014). Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine. PMC. 1 indexed citations
4.
Wyatt, Christina, Douglas Kitch, Samir K. Gupta, et al.. (2014). Changes in Proteinuria and Albuminuria With Initiation of Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(1). 36–44. 14 indexed citations
5.
Gupta, Samir K., Douglas Kitch, Camlin Tierney, et al.. (2014). Cystatin C-Based Renal Function Changes After Antiretroviral Initiation: A Substudy of a Randomized Trial. Open Forum Infectious Diseases. 1(1). ofu003–ofu003. 8 indexed citations
6.
McComsey, Grace A., Douglas Kitch, Paul E. Sax, et al.. (2013). Associations of Inflammatory Markers With AIDS and Non-AIDS Clinical Events After Initiation of Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(2). 167–174. 52 indexed citations
7.
Erlandson, Kristine M., Douglas Kitch, Camlin Tierney, et al.. (2013). Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density. AIDS. 27(13). 2069–2079. 37 indexed citations
8.
Sax, Paul E., Camlin Tierney, Ann C. Collier, et al.. (2011). Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results. The Journal of Infectious Diseases. 204(8). 1191–1201. 130 indexed citations
9.
McComsey, Grace A., Douglas Kitch, Eric S. Daar, et al.. (2011). Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202. The Journal of Infectious Diseases. 203(12). 1791–1801. 381 indexed citations breakdown →
10.
Goicoechea, Miguel, Sonia Jain, Carol A. Kemper, et al.. (2010). Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients. AIDS. 24(5). 707–716. 13 indexed citations
11.
Young, Benjamin, Edwin DeJesus, Trevor Hawkins, et al.. (2010). A Pilot Study of Abacavir/Lamivudine and Raltegravir in Antiretroviral-Naïve HIV-1–Infected Patients: 48-Week Results of the SHIELD Trial. HIV Clinical Trials. 11(5). 260–269. 17 indexed citations
12.
Watson, Maria, Lisa Patel, Belinda Ha, et al.. (2009). A Study of HIV Provider Attitudes Toward HLA-B*5701 Testing in the United States. AIDS Patient Care and STDs. 23(11). 957–963. 3 indexed citations
13.
14.
Sax, Paul E., Camlin Tierney, Ann C. Collier, et al.. (2009). Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy. New England Journal of Medicine. 361(23). 2230–2240. 215 indexed citations
15.
Goicoechea, Miguel, Sonia Jain, Shelly Sun, et al.. (2009). Interlaboratory Measurement Differences in Intracellular Carbovir Triphosphate Concentrations in HIV‐Infected Patients: Sources of Variability in Processing, Shipping, and Quantitation. The Journal of Clinical Pharmacology. 50(8). 968–974. 5 indexed citations
16.
Elion, Richard, Edwin DeJesus, Michael Sension, et al.. (2008). Once-Daily Abacavir/Lamivudine and Ritonavir-Boosted Atazanavir for the Treatment of HIV-1 Infection in Antiretroviral-Naïve Patients: A 48-Week Pilot Study. HIV Clinical Trials. 9(3). 152–163. 21 indexed citations
17.
Elion, Richard, Calvin Cohen, Edwin DeJesus, et al.. (2006). Once-Daily Abacavir/Lamivudine/Zidovudine plus Tenofovir for the Treatment of HIV-1 Infection in Antiretroviral-NaïveSubjects: A 48-Week Pilot Study. HIV Clinical Trials. 7(6). 324–333. 12 indexed citations
18.
Yim, Peter J., Belinda Ha, G. William Henry, et al.. (1998). Diastolic shape of the right ventricle of the heart. The Anatomical Record. 250(3). 316–324. 6 indexed citations
19.
Katayama, Hiroshi, et al.. (1996). Pulmonary blood flow profiles with reduced right ventricular function in lambs. Heart and Vessels. 11(2). 57–63.
20.
Katayama, Hiroshi, et al.. (1992). Three-Dimensional Visualization of Pulmonary Blood Flow Velocity Profiles in Lambs. Japanese Heart Journal. 33(1). 95–111. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henning Drechsler Breakdown of academic impact, for papers by S. Lawson‐Ayayi Breakdown of academic impact, for papers by Allison Ross Eckard Breakdown of academic impact, for papers by Aoife G. Cotter Breakdown of academic impact, for papers by Beverly Alston‐Smith Breakdown of academic impact, for papers by Roula Qaqish Breakdown of academic impact, for papers by Allison C. Ross Breakdown of academic impact, for papers by Paola Cicconi Breakdown of academic impact, for papers by Jean‐Philippe Chave Breakdown of academic impact, for papers by Valerianna Amorosa
Rankless by CCL
2026